Measurement of teicoplanin by liquid chromatography-tandem mass spectrometry:development of a novel method [PDF]
, 2012 Teicoplanin is an antibiotic used for the treatment of endocarditis, osteomyelitis, septic arthritis and methicillin-resistant Staphylococcus aureus. Teicoplanin is emerging as a suitable alternative antibiotic to vancomycin, where their trough serum ...
Bailey, Lisa M +5 more
core +1 more source
High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding. [PDF]
HaemophiliaABSTRACT Introduction Heavy menstrual bleeding (HMB) is a common presenting symptom in women with bleeding disorders, yet haemostatic testing is sometimes overlooked, even when refractory HMB requires surgical intervention. Aim To determine the prevalence of bleeding disorders in women referred for surgical management of HMB and investigate screening ...
Delaney A +8 more
europepmc +2 more sources
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. [PDF]
Journal of Clinical Investigation, 1973 H. Weiss, J. Rogers, H. Brand
semanticscholar +2 more sources
A few atoms make the difference: Synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives [PDF]
, 2018 K
Batta, Gyula +14 more
core +1 more source
Laboratory Diagnosis of von Willebrand's Disease
Indonesian Biomedical Journal, 2009 von Willebrand's disease (vWD) is an autosomally inherited bleeding disorder caused by a deficiency or abnormality of von Willebrand factor (vWF). vWF is a multimeric adhesive protein that plays an important role in primary hemostasis by promoting ...
Mansyur Arif
doaj +1 more source
Diagnosis of von Willebrand disease in Argentina: a single institution experience [PDF]
, 2017 von Willebrand disease (VWD) is the most common autosomal bleeding disorder, mostlyinherited as dominant trait. VWD is due to deficiency/abnormality of von Willebrand factor (VWF).
Blanco, Alicia Noemi +5 more
core +1 more source
Einfluss niedermolekularer Hydroxyethylstärke unterschiedlicher Ausgangssubstanz auf die Hämostase [PDF]
, 2006 Die Infusion von Hydroxyethylstärke (HES) kann potentiell über verschiedene Mechanismen die Hämostase beeinflussen. Aufgrund der Variabilität des HES- Moleküls steht eine Vielfalt an Präparaten mit unterschiedlichen pharmakologischen und -kinetischen ...
Karopka,Susanne, Zeiler, Thomas (Dr.)
core +1 more source
Journal of Pharmacological Sciences, 2008 To obtain compounds that inhibit the interaction of von Willebrand factor (vWF) and glycoprotein (GP) Ib, a novel binding assay was established. The binding of fixed platelets to vWF-R497 mutant was quantified by a solid phase assay. In this assay, fixed
Kenji Hayata +3 more
doaj +1 more source
Haematologica, 2007 Background and Objectives von Willebrand’s disease (VWD) is a heterogeneous bleeding disorder caused by quantitative or qualitative defects in von Willebrand factor (VWF). The diagnosis of VWD requires several laboratory tests.
Silvia Giannini +3 more
doaj +1 more source
MISDIAGNOSIS OF ACQUIRED VON WILLEBRAND DISEASE
Hematology, Transfusion and Cell Therapy, 2023 Introduction: The diagnosis of acquired von willebrand disease (VWD) is a challenge for laboratory investigation. Alloantibodies may present different kinetics of FVW neutralization and thus generate inconclusive results.
AP Francisco +4 more
doaj +1 more source